IDEXX Laboratories Inc IDXX
$676.21 −$13.44 (-1.95%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $674.72 -0.22%
Open$688.61
Prev close$689.65
Day range$672.72 – $696.89
Volume614.4K
Market cap$53.28B
P/E (TTM)45.6
Dividend yield–
IDXX Stock News
Headlines matching IDEXX Laboratories Inc or the IDXX ticker, most recent first.
- UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $670
- Analysts Conflicted on These NA Names: Rapport Therapeutics, Inc. (RAPP), Idexx Laboratories (IDXX) and Waystar Holding Corp. (WAY)
- Citi Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670 Positive
- UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670 Positive
- Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $805
- Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $675
- BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $665 Positive
- William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating
- Barclays Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $710 Negative
- BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $660
- UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $620 Negative
- Jefferies Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $729 Negative
- BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $660 Negative
- BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $790
- UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $640 Negative
No comments yet — be the first to weigh in on IDXX.
Sign in to join the discussion.